Kepley BioSystems Inc

Kepley BioSystems is a North Carolina-based life-sciences development company founded in 2013 that operates as an academically seated invention hothouse. Utilizing a business model focused on securing non-dilutive government research grants, the company develops various technologies with the goal of spinning them out into independent entities. Their internal research and development programs address complex social and environmental challenges, leveraging affiliations with academic institutions and state-of-the-art laboratory facilities to drive innovation across multiple industries.

The company’s primary projects include the development of synthetic alternatives to horseshoe crab blood for endotoxin testing and rapid diagnostic tools for identifying bloodborne pathogens to combat antimicrobial resistance and sepsis. By focusing on sustainable biological resources and medical diagnostics, Kepley BioSystems seeks to provide global solutions to critical healthcare issues. Through their ongoing collaborations and institutionalized grant-writing expertise, they aim to translate scientific research into viable products that support global competitiveness and medical progress.